NIH/ADAMHA recognize that under the FTTA and the patent licensing law to which it refers, Congress and the President have chosen to utilize the patent system as the primary mechanism for transferring Government inventions to the private sector. The... Implementation of the Federal Technology Transfer Act: Hearing Before the ... - Page 179by United States. Congress. House. Committee on Science, Space, and Technology. Subcommittee on Science, Research, and Technology - 1989 - 565 pagesFull view - About this book
| United States. Congress. House. Committee on Appropriations. Subcommittee on the Departments of Commerce, Justice, and State, the Judiciary, and Related Agencies - 1987 - 1128 pages
...injunction and criminal proceedings in the US District Courts. This Act was amended on September 24, 1984, by the Drug Price Competition and Patent Term Restoration Act of 1984, Pub. L. No. 98-417, $S 301-307, 98 Stat. 1585, 1603, to require that a textile fiber product processed or manufactured... | |
| United States. Congress. House. Select Committee on Aging - 1990 - 58 pages
...surge in competition from generic products as soon as the patent on the pioneer drug expires, spurred by the Drug Price Competition and Patent Term Restoration Act of 1984. That Act, together with generic drug substitution laws in the states, results in a virtual collapse... | |
| United States. Congress. Senate. Committee on Labor and Human Resources - 1991 - 254 pages
...competition from generic products as soon as the patent on a pioneer drug expires. This action was spurred by the Drug Price Competition and Patent Term Restoration Act of 1984, which was a watershed act for the industry. That act together with generic drug substitution laws in... | |
| United States. Congress. Senate. Committee on Labor and Human Resources - 1991 - 248 pages
...competition from generic products as soon as the patent on a pioneer drug expires. This action was spurred by the Drug Price Competition and Patent Term Restoration Act of 1984, which was a watershed act for the industry. That act together with generic drug substitution laws in... | |
| |